Tim Lammens

4.7k total citations
64 papers, 1.9k citations indexed

About

Tim Lammens is a scholar working on Molecular Biology, Cancer Research and Hematology. According to data from OpenAlex, Tim Lammens has authored 64 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 22 papers in Cancer Research and 17 papers in Hematology. Recurrent topics in Tim Lammens's work include Acute Myeloid Leukemia Research (15 papers), Acute Lymphoblastic Leukemia research (12 papers) and Cancer-related molecular mechanisms research (11 papers). Tim Lammens is often cited by papers focused on Acute Myeloid Leukemia Research (15 papers), Acute Lymphoblastic Leukemia research (12 papers) and Cancer-related molecular mechanisms research (11 papers). Tim Lammens collaborates with scholars based in Belgium, Netherlands and France. Tim Lammens's co-authors include Lieven De Veylder, Dirk Inzé, Véronique Boudolf, Gustavo Leone, Jing Li, Éva Kondorosi, Sara Maes, Barbara De Moerloose, Yves Benoît and Pieter Van Vlierberghe and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The EMBO Journal.

In The Last Decade

Tim Lammens

58 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tim Lammens Belgium 23 1.3k 710 410 262 232 64 1.9k
Andreas Kloetgen United States 18 1.2k 1.0× 278 0.4× 314 0.8× 164 0.6× 48 0.2× 30 1.5k
Giovanna Grimaldi Italy 22 1.5k 1.2× 329 0.5× 368 0.9× 274 1.0× 45 0.2× 44 2.0k
John Maciejowski United States 21 1.9k 1.5× 256 0.4× 363 0.9× 350 1.3× 121 0.5× 37 2.5k
Anneke B. Oostra Netherlands 25 2.6k 2.1× 318 0.4× 768 1.9× 389 1.5× 179 0.8× 37 2.9k
Csanád Z. Bachrati United Kingdom 20 2.3k 1.8× 411 0.6× 561 1.4× 310 1.2× 56 0.2× 32 2.5k
Anthony Tubbs United States 16 2.0k 1.6× 123 0.2× 329 0.8× 677 2.6× 62 0.3× 19 2.3k
Alison A. Bertuch United States 27 1.4k 1.1× 177 0.2× 112 0.3× 209 0.8× 81 0.3× 77 2.2k
Sally‐Anne Stephenson Australia 19 687 0.5× 198 0.3× 249 0.6× 222 0.8× 39 0.2× 34 1.3k
Maria Jasin United States 19 2.8k 2.3× 375 0.5× 479 1.2× 720 2.7× 86 0.4× 23 3.2k
Luigi Nezi Italy 13 1.5k 1.2× 254 0.4× 259 0.6× 326 1.2× 49 0.2× 26 1.9k

Countries citing papers authored by Tim Lammens

Since Specialization
Citations

This map shows the geographic impact of Tim Lammens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Lammens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Lammens more than expected).

Fields of papers citing papers by Tim Lammens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Lammens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Lammens. The network helps show where Tim Lammens may publish in the future.

Co-authorship network of co-authors of Tim Lammens

This figure shows the co-authorship network connecting the top 25 collaborators of Tim Lammens. A scholar is included among the top collaborators of Tim Lammens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim Lammens. Tim Lammens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moerloose, Barbara De, et al.. (2025). Prime-time for LncRNA signatures in acute myeloid leukemia?. Annals of Hematology. 104(9). 4333–4345.
2.
Amaral, Patrícia, David Gresham, Jonathan Bond, et al.. (2025). Underlying biology, challenges and emergent concepts in the treatment of relapsed and refractory pediatric T-cell acute lymphoblastic leukemia. Leukemia. 39(11). 2575–2589.
3.
Dijk, Freerk van, Lars T. van der Veken, Manon M. H. Huibers, et al.. (2025). Exploring germline variants in genes associated with inborn errors of immunity and inherited bone marrow failure syndromes in pediatric hematological malignancies. European Journal of Cancer. 226. 115598–115598. 1 indexed citations
4.
Schalk, Amanda M., Katrien Vandemeulebroecke, Ying Su, et al.. (2024). A human-like glutaminase-free asparaginase is highly efficacious in ASNSlow leukemia and solid cancer mouse xenograft models. Cancer Letters. 611. 217404–217404. 1 indexed citations
5.
Moerloose, Barbara De, et al.. (2024). A 69 long noncoding RNA signature predicts relapse and acts as independent prognostic factor in pediatric AML. Blood Advances. 8(12). 3299–3310. 3 indexed citations
6.
Linden, Malaïka Van Der, Christophe Chantrain, Laurence Dedeken, et al.. (2024). Acute myeloid leukemia stem cell signature gene EMP1 is not an eligible therapeutic target. Pediatric Research. 97(1). 160–168.
7.
Schalk, Amanda M., Veerle Mondelaers, Barbara De Moerloose, et al.. (2022). Novel Insights on the Use of L-Asparaginase as an Efficient and Safe Anti-Cancer Therapy. Cancers. 14(4). 902–902. 82 indexed citations
8.
Uyttebroeck, Anne, An Van Damme, Laurence Dedeken, et al.. (2022). Deciphering the Non-Coding RNA Landscape of Pediatric Acute Myeloid Leukemia. Cancers. 14(9). 2098–2098. 5 indexed citations
9.
Elliott, Kerryn, Joris Van de Velde, A. Claeys, et al.. (2022). A clinically annotated post-mortem approach to study multi-organ somatic mutational clonality in normal tissues. Scientific Reports. 12(1). 10322–10322. 2 indexed citations
10.
Schalk, Amanda M., Hien Anh Thi Nguyen, Katrien Vandemeulebroecke, et al.. (2022). <i>In vivo</i> stabilization of a less toxic asparaginase variant leads to a durable antitumor response in acute leukemia. Haematologica. 108(2). 409–419. 12 indexed citations
11.
Lammens, Tim, Ying Wu, Miriam Erlacher, et al.. (2021). Long non-coding RNAs as novel therapeutic targets in juvenile myelomonocytic leukemia. Scientific Reports. 11(1). 2801–2801. 13 indexed citations
12.
Lammens, Tim, Alina Ferster, Miriam Erlacher, et al.. (2021). Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignancies. Leukemia. 35(11). 3304–3308. 10 indexed citations
13.
Moerloose, Barbara De, Ardine Reedijk, Geertruida H. de Bock, et al.. (2019). Response‐guided chemotherapy for pediatric acute myeloid leukemia without hematopoietic stem cell transplantation in first complete remission: Results from protocol DB AML‐01. Pediatric Blood & Cancer. 66(5). e27605–e27605. 23 indexed citations
14.
Bomken, Simon, Jutte van der Werff ten Bosch, Andishe Attarbaschi, et al.. (2018). Current Understanding and Future Research Priorities in Malignancy Associated With Inborn Errors of Immunity and DNA Repair Disorders: The Perspective of an Interdisciplinary Working Group. Frontiers in Immunology. 9. 2912–2912. 40 indexed citations
15.
Vandepoele, Karl, Araceli Diez‐Fraile, Katrien Vandemeulebroecke, et al.. (2018). Pinpointing a potential role for CLEC12B in cancer predisposition through familial exome sequencing. Pediatric Blood & Cancer. 66(2). e27513–e27513. 5 indexed citations
16.
Roy, Nadine Van, Malaïka Van Der Linden, Björn Menten, et al.. (2017). Shallow Whole Genome Sequencing on Circulating Cell-Free DNA Allows Reliable Noninvasive Copy-Number Profiling in Neuroblastoma Patients. Clinical Cancer Research. 23(20). 6305–6314. 81 indexed citations
17.
Ghazavi, Farzaneh, Tim Lammens, Nadine Van Roy, et al.. (2015). Molecular basis and clinical significance of genetic aberrations in B-cell precursor acute lymphoblastic leukemia. Experimental Hematology. 43(8). 640–653. 17 indexed citations
18.
Berckmans, Barbara, Tim Lammens, Hilde Van den Daele, et al.. (2011). Light-Dependent Regulation of DEL1 Is Determined by the Antagonistic Action of E2Fb and E2Fc    . PLANT PHYSIOLOGY. 157(3). 1440–1451. 50 indexed citations
19.
Lammens, Tim, Jing Li, Gustavo Leone, & Lieven De Veylder. (2009). Atypical E2Fs: new players in the E2F transcription factor family. Trends in Cell Biology. 19(3). 111–118. 174 indexed citations
20.
Takahashi, Naoki, Tim Lammens, Véronique Boudolf, et al.. (2008). The DNA replication checkpoint aids survival of plants deficient in the novel replisome factor ETG1. The EMBO Journal. 27(13). 1840–1851. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andreas Kloetgen Breakdown of academic impact, for papers by Giovanna Grimaldi Breakdown of academic impact, for papers by John Maciejowski Breakdown of academic impact, for papers by Anneke B. Oostra Breakdown of academic impact, for papers by Csanád Z. Bachrati Breakdown of academic impact, for papers by Anthony Tubbs Breakdown of academic impact, for papers by Alison A. Bertuch Breakdown of academic impact, for papers by Sally‐Anne Stephenson Breakdown of academic impact, for papers by Maria Jasin Breakdown of academic impact, for papers by Luigi Nezi
Rankless by CCL
2026